Table 5. Multivariate association of survival with name, lipophilicity, potency, intensity of statin use after diagnosis of pancreatic adenocarcinoma.

Variables	Category	adjusted HR (95%) for death	P-value
Statin name
	Atorvastatin vs. no statin	0.97 (0.87, 1.09)	0.59
	Lovastatin vs. no statin	0.96 (0.85, 1.08)	0.48
	Pravastatin vs. no statin	1.07 (0.88, 1.30)	0.53
	Rosuvastatin vs. no statin	0.98 (0.79, 1.23)	0.87
	Simvastatin vs. no statin	0.91 (0.84, 0.99)	0.03
Statin type
	Hydrophilic vs. no statin	1.02 (0.87, 1.18)	0.85
	Lipophilic vs. no statin	0.94 (0.88, 1.01)	0.08
Statin potency
	High potency vs. no statin	0.93 (0.86, 1.00)	0.035
	Low potency vs. no statin	0.99 (0.89, 1.10)	0.8
Statin intensity
	Low vs. no statin	0.85 (0.75, 0.97)	0.02
	Moderate vs. no statin	0.97 (0.90, 1.04)	0.35
	High vs. no statin	0.97 (0.84, 1.11)	0.65